Market Overview

Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest EPS Estimates

Related UTHR
Earnings Scheduled For February 24, 2015
What Investors Are Looking At In The Stem Cell Sector
Related ENDP
Analyst: Boston Scientific's Acquisition Is 'Strategically Sound'
Benzinga's M&A Chatter for Monday March 2, 2015
FDA imposes limits on testosterone drugs and labeling changes to warn of potential heart risks (Seeking Alpha)

Below are the top drug manufacturers-other stocks on the NASDAQ in terms of earnings estimate for the next year.

United Therapeutics (NASDAQ: UTHR) is likely to earn $6.96 per share in the next year ending December, 2014. United Therapeutics' trailing-twelve-month ROE is 24.83%.

Endo Health Solutions (NASDAQ: ENDP) may earn $3.83 per share in the next year ending December, 2014. Endo Health's trailing-twelve-month revenue is $3.03 billion.

The Medicines Company (NASDAQ: MDCO) is projected to earn $1.15 per share for the next year ending December, 2014. Medicines Company's trailing-twelve-month operating margin is 16.42%.

Cubist Pharmaceuticals (NASDAQ: CBST) is expected to earn $1.14 per share over the next year ending December, 2014. Cubist's trailing-twelve-month ROA is 2.54%.

Posted-In: Drug Manufacturers-Other Industry EPS Estimates NASDAQTrading Ideas


Related Articles (CBST + ENDP)

Around the Web, We're Loving...

Get Benzinga's Newsletters